News
KNW
0.6510
-7.00%
-0.0490
KNW Stock Earnings: Know Labs Misses EPS for Q2 2024
Know Labs reported earnings per share of -7 cents for the second quarter of 2024. The company did not report any revenue for the quarter. This was below the analyst estimate for EPS of -2 cents. Know Labs reported no earnings for the first quarter of 2025.
Investorplace · 2d ago
Know Labs, Inc. Quarterly Report on Form 10-Q
Press release · 2d ago
Know Labs Q2 2024 GAAP EPS $(0.07) Misses $(0.05) Estimate
Benzinga · 2d ago
Know Labs GAAP EPS of -$0.07
Seeking Alpha · 2d ago
*Know Labs 2Q Loss/Shr 7c >KNW
Dow Jones · 2d ago
Press Release: Know Labs, Inc. Reports Second -2-
Three months ended March 31, 2018, the Company recorded a net loss of $8.1 million. The Company's net loss for the quarter was $7.2 million. The Company has a total of $9.7 million in cash and cash equivalents. The company has no debt and no borrowings. The Corporation's stockholders' equity is based on the Company's common stock.
Dow Jones · 2d ago
Press Release: Know Labs, Inc. Reports Second Quarter FY 2024 Results
Know Labs, Inc. Reports Second Quarter FY 2024 Results. Know Labs is a leading developer of non-invasive medical diagnostic technology. The company reported an operating loss of $ million in the second quarter of the fiscal year 2024 ended March 31, 2024. The Company had cash and cash equivalents of $1.2 million as of March 31.
Dow Jones · 2d ago
Weekly Report: what happened at KNW last week (0506-0510)?
Weekly Report · 5d ago
Know Labs To Present Clinical Research At 2024 American Association Of Clinical Endocrinology Annual Meeting
Benzinga · 05/09 13:16
Press Release: Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
Know Labs, Inc. To Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024. Know Labs is developing the first FDA-cleared non-invasive continuous blood glucose monitoring device. The company will host a webcast to review business updates and results for its second quarter of the fiscal year 2024.
Dow Jones · 05/08 13:04
Weekly Report: what happened at KNW last week (0429-0503)?
Weekly Report · 05/06 12:32
Weekly Report: what happened at KNW last week (0422-0426)?
Weekly Report · 04/29 12:42
Weekly Report: what happened at KNW last week (0415-0419)?
Weekly Report · 04/22 12:23
Weekly Report: what happened at KNW last week (0408-0412)?
Weekly Report · 04/15 12:13
Weekly Report: what happened at KNW last week (0401-0405)?
Weekly Report · 04/08 12:19
Know Labs Price Target Announced at $1.00/Share by Benchmark
Dow Jones · 04/08 12:14
Know Labs Initiated at Speculative Buy by Benchmark
Dow Jones · 04/08 12:14
KNOW LABS INC <KNW.A>: BENCHMARK INITIATES COVERAGE WITH SPECULATIVE BUY RATING ; TARGET PRICE $1
Reuters · 04/08 10:08
Weekly Report: what happened at KNW last week (0325-0329)?
Weekly Report · 04/01 12:15
Weekly Report: what happened at KNW last week (0318-0322)?
Weekly Report · 03/25 12:19
More
Webull provides a variety of real-time KNW stock news. You can receive the latest news about Know Labs through multiple platforms. This information may help you make smarter investment decisions.
About KNW
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Company’s Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Company’s trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.